Concord Wealth Partners Novavax Inc Transaction History

Concord Wealth Partners

  • $591 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$36.28 - $75.29 $507 - $1,054
-14 Closed
0 $0
Q1 2022

Apr 20, 2022
BUY
$69.73 - $142.9 $976 - $2,000
14 New
14 $1,000
Q1 2021

May 13, 2021
SELL
$112.98 - $319.93 $564 - $1,599
-5 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$78.74 - $139.5 $393 - $697
5 New
5 $1,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email